The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Universal CAR-T Cell Therapy Market Research Report 2024

Global Universal CAR-T Cell Therapy Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1893842

No of Pages : 89

Ask Your Query
Synopsis
Off-the-shelf CAR-T cells are CAR-T cells prepared using allogeneic T cells, also known as "off-the-shelf" and universal. Usually, T cells are collected from healthy donors or T cells derived from stem cells are used directly. After HLA matching, a successfully designed CAR (such as CD19 CAR) is loaded onto the surface of the T cells.
The global Universal CAR-T Cell Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Universal CAR-T Cell Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Universal CAR-T Cell Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Universal CAR-T Cell Therapy in Hematoma is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Universal CAR-T Cell Therapy include Cellectis, Allogene, Caribou, Poseida Therapeutics, Bangyao Biotechnology, Usano, Keji Pharmaceutical, Beiheng Biotechnology and Grace Biotechnology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Universal CAR-T Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Universal CAR-T Cell Therapy.
Report Scope
The Universal CAR-T Cell Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Universal CAR-T Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Universal CAR-T Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cellectis
Allogene
Caribou
Poseida Therapeutics
Bangyao Biotechnology
Usano
Keji Pharmaceutical
Beiheng Biotechnology
Grace Biotechnology
Celyad
CRISPR Therapeutics
Precision BioSciences
Segment by Type
First Generation CARs
Second Generation CARs
Third Generation CARs
Segment by Application
Hematoma
Solid Tumor
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Universal CAR-T Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Universal CAR-T Cell Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 First Generation CARs
1.2.3 Second Generation CARs
1.2.4 Third Generation CARs
1.3 Market by Application
1.3.1 Global Universal CAR-T Cell Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hematoma
1.3.3 Solid Tumor
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Universal CAR-T Cell Therapy Market Perspective (2019-2030)
2.2 Universal CAR-T Cell Therapy Growth Trends by Region
2.2.1 Global Universal CAR-T Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Universal CAR-T Cell Therapy Historic Market Size by Region (2019-2024)
2.2.3 Universal CAR-T Cell Therapy Forecasted Market Size by Region (2025-2030)
2.3 Universal CAR-T Cell Therapy Market Dynamics
2.3.1 Universal CAR-T Cell Therapy Industry Trends
2.3.2 Universal CAR-T Cell Therapy Market Drivers
2.3.3 Universal CAR-T Cell Therapy Market Challenges
2.3.4 Universal CAR-T Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Universal CAR-T Cell Therapy Players by Revenue
3.1.1 Global Top Universal CAR-T Cell Therapy Players by Revenue (2019-2024)
3.1.2 Global Universal CAR-T Cell Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Universal CAR-T Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Universal CAR-T Cell Therapy Revenue
3.4 Global Universal CAR-T Cell Therapy Market Concentration Ratio
3.4.1 Global Universal CAR-T Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Universal CAR-T Cell Therapy Revenue in 2023
3.5 Universal CAR-T Cell Therapy Key Players Head office and Area Served
3.6 Key Players Universal CAR-T Cell Therapy Product Solution and Service
3.7 Date of Enter into Universal CAR-T Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Universal CAR-T Cell Therapy Breakdown Data by Type
4.1 Global Universal CAR-T Cell Therapy Historic Market Size by Type (2019-2024)
4.2 Global Universal CAR-T Cell Therapy Forecasted Market Size by Type (2025-2030)
5 Universal CAR-T Cell Therapy Breakdown Data by Application
5.1 Global Universal CAR-T Cell Therapy Historic Market Size by Application (2019-2024)
5.2 Global Universal CAR-T Cell Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Universal CAR-T Cell Therapy Market Size (2019-2030)
6.2 North America Universal CAR-T Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Universal CAR-T Cell Therapy Market Size by Country (2019-2024)
6.4 North America Universal CAR-T Cell Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Universal CAR-T Cell Therapy Market Size (2019-2030)
7.2 Europe Universal CAR-T Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Universal CAR-T Cell Therapy Market Size by Country (2019-2024)
7.4 Europe Universal CAR-T Cell Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Universal CAR-T Cell Therapy Market Size (2019-2030)
8.2 Asia-Pacific Universal CAR-T Cell Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Universal CAR-T Cell Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Universal CAR-T Cell Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Universal CAR-T Cell Therapy Market Size (2019-2030)
9.2 Latin America Universal CAR-T Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Universal CAR-T Cell Therapy Market Size by Country (2019-2024)
9.4 Latin America Universal CAR-T Cell Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Universal CAR-T Cell Therapy Market Size (2019-2030)
10.2 Middle East & Africa Universal CAR-T Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Universal CAR-T Cell Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Universal CAR-T Cell Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cellectis
11.1.1 Cellectis Company Detail
11.1.2 Cellectis Business Overview
11.1.3 Cellectis Universal CAR-T Cell Therapy Introduction
11.1.4 Cellectis Revenue in Universal CAR-T Cell Therapy Business (2019-2024)
11.1.5 Cellectis Recent Development
11.2 Allogene
11.2.1 Allogene Company Detail
11.2.2 Allogene Business Overview
11.2.3 Allogene Universal CAR-T Cell Therapy Introduction
11.2.4 Allogene Revenue in Universal CAR-T Cell Therapy Business (2019-2024)
11.2.5 Allogene Recent Development
11.3 Caribou
11.3.1 Caribou Company Detail
11.3.2 Caribou Business Overview
11.3.3 Caribou Universal CAR-T Cell Therapy Introduction
11.3.4 Caribou Revenue in Universal CAR-T Cell Therapy Business (2019-2024)
11.3.5 Caribou Recent Development
11.4 Poseida Therapeutics
11.4.1 Poseida Therapeutics Company Detail
11.4.2 Poseida Therapeutics Business Overview
11.4.3 Poseida Therapeutics Universal CAR-T Cell Therapy Introduction
11.4.4 Poseida Therapeutics Revenue in Universal CAR-T Cell Therapy Business (2019-2024)
11.4.5 Poseida Therapeutics Recent Development
11.5 Bangyao Biotechnology
11.5.1 Bangyao Biotechnology Company Detail
11.5.2 Bangyao Biotechnology Business Overview
11.5.3 Bangyao Biotechnology Universal CAR-T Cell Therapy Introduction
11.5.4 Bangyao Biotechnology Revenue in Universal CAR-T Cell Therapy Business (2019-2024)
11.5.5 Bangyao Biotechnology Recent Development
11.6 Usano
11.6.1 Usano Company Detail
11.6.2 Usano Business Overview
11.6.3 Usano Universal CAR-T Cell Therapy Introduction
11.6.4 Usano Revenue in Universal CAR-T Cell Therapy Business (2019-2024)
11.6.5 Usano Recent Development
11.7 Keji Pharmaceutical
11.7.1 Keji Pharmaceutical Company Detail
11.7.2 Keji Pharmaceutical Business Overview
11.7.3 Keji Pharmaceutical Universal CAR-T Cell Therapy Introduction
11.7.4 Keji Pharmaceutical Revenue in Universal CAR-T Cell Therapy Business (2019-2024)
11.7.5 Keji Pharmaceutical Recent Development
11.8 Beiheng Biotechnology
11.8.1 Beiheng Biotechnology Company Detail
11.8.2 Beiheng Biotechnology Business Overview
11.8.3 Beiheng Biotechnology Universal CAR-T Cell Therapy Introduction
11.8.4 Beiheng Biotechnology Revenue in Universal CAR-T Cell Therapy Business (2019-2024)
11.8.5 Beiheng Biotechnology Recent Development
11.9 Grace Biotechnology
11.9.1 Grace Biotechnology Company Detail
11.9.2 Grace Biotechnology Business Overview
11.9.3 Grace Biotechnology Universal CAR-T Cell Therapy Introduction
11.9.4 Grace Biotechnology Revenue in Universal CAR-T Cell Therapy Business (2019-2024)
11.9.5 Grace Biotechnology Recent Development
11.10 Celyad
11.10.1 Celyad Company Detail
11.10.2 Celyad Business Overview
11.10.3 Celyad Universal CAR-T Cell Therapy Introduction
11.10.4 Celyad Revenue in Universal CAR-T Cell Therapy Business (2019-2024)
11.10.5 Celyad Recent Development
11.11 CRISPR Therapeutics
11.11.1 CRISPR Therapeutics Company Detail
11.11.2 CRISPR Therapeutics Business Overview
11.11.3 CRISPR Therapeutics Universal CAR-T Cell Therapy Introduction
11.11.4 CRISPR Therapeutics Revenue in Universal CAR-T Cell Therapy Business (2019-2024)
11.11.5 CRISPR Therapeutics Recent Development
11.12 Precision BioSciences
11.12.1 Precision BioSciences Company Detail
11.12.2 Precision BioSciences Business Overview
11.12.3 Precision BioSciences Universal CAR-T Cell Therapy Introduction
11.12.4 Precision BioSciences Revenue in Universal CAR-T Cell Therapy Business (2019-2024)
11.12.5 Precision BioSciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock